The reproducibility of cardiac and liver T2 measurement in thalassemia major using two different software packages

International Journal of Cardiovascular Imaging

Volumn 29, Issue 7, 2013, Pages 1511-1516

  Mavrogeni, Sophie ^a   Bratis, Konstantinos ^a   Van Wijk, Kees ^b   Kyrou, Louisa ^c   Kattamis, Antonios ^d   Reiber, Johan H C ^e  

^a ONASSIS CARDIAC SURGERY CENTER   (Greece)

^b Medis Medical Imaging Systems bv   (Netherlands)

^c BIOIATRIKI HEALTHCARE GROUP   (Greece)

^d AGHIA SOPHIA CHILDREN S HOSPITAL   (Greece)

^e LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular magnetic resonance; MR validation; Quantitative MR; T2 mapping; Thalassemia major

Indexed keywords

DEFEROXAMINE;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; IMAGING SOFTWARE; INTERMETHOD COMPARISON; IRON OVERLOAD; LIVER; MALE; MEASUREMENT; MEASUREMENT ACCURACY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SCANNER; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SURVIVAL; THALASSEMIA MAJOR; YOUNG ADULT;

EID: 84893667737     PISSN: 15695794     EISSN: 15730743     Source Type: Journal    
DOI: 10.1007/s10554-013-0242-6     Document Type: Article

References (22)

1. Modell B, Berdoukas V (1984) The clinical approach to Thalassemia. Grune & Stratton, New York, NY
2. Zurlo MG, De Stefano P, Borgna-pignatti C (1989) Survival and causes of death in thalassemia major. Lancet 2:27-30
3. Buja LM, Roberts WC (1971) Iron in the heart: etiology and clinical significance. Am J Med 51:209-221
4. Engle MA (1969) Cardiac involvement in Cooley?s anemia. Ann NY Acad Sci 119:694-702
5. Jacobs A (1980) The pathology of iron overload. In: Jacobs A, Worwood M (eds) Iron in biochemistry and medicine, II. Academic Press, New York, pp 439-452
6. Jacobs A, Miller F, Worwood M, Beamisch R, et al. Ferritin in the serum of normal subjects with iron deficiency and iron overload. Br Med J 1972: 206-11
7. Crosby WH (1976) Serum ferritin fails to indicate hemochromatosis: nothing gold can stay. N Engl J Med 294:333-334
8. Barry M, Sherlock S (1971) Measurement of liver iron concentration in liver biopsy specimens. Lancet 1:100-103
9. Brittenham GM, Badman DG (2003) Noninvasive measurement of iron: report of an NIDDK workshop. Blood 101:15-19
10. Liu P, Henkelman M, Joshi J et al (1996) Quantification of cardiac and tissue iron by nuclear magnetic resonance relaxometry in a novel murine thalassemia-cardiac iron overload model. Can J Cardiol 12:155-164
11. Mavrogeni S, Gotsis E, Ladis V, Berdousis E, Verganelakis D, Toulas P, Cokkinos DV (2008) Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major. Int J Cardiovasc Imaging 24:849-854
12. Anderson LJ, Holden S, Davis B, Prescott E, Charrier CC, Bunce NH, Firmin DN, Wonke B, Porter J, Walker JM et al (2001) Cardiovascular t2-star (t2) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J 22:2171-2179
13. McKee PA, Castelli WP, McNamara PM et al (1971) The natural history of congestive heart failure the Framingham Study. N Engl J Med 285:1441-1446
14. Wood JC, Enriquez C, Ghugre N et al (2005) MRI R2 and R2 mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood 106:1460-1465
15. Ramazzotti A, Pepe A, Positano V, Rossi G, De Marchi D, Brizi MG, Luciani A, Midiri M, Sallustio G, Valeri G, Caruso V, Centra M, Cianciulli P, De Sanctis V, Maggio A, Lombardi M (2009) Multicenter validation of the magnetic resonance T2 technique for segmental and global quantification of myocardial iron. J Magn Reson Imaging 30(1):62-68
16. Westwood MA, Firmin DN, Gildo M, Renzo G, Stathis G, Markissia K, Vasili B, Pennell DJ (2005) Intercentre reproducibility of magnetic resonance T2 measurements of myocardial iron in thalassaemia. Int J Cardiovasc Imaging 21(5):531-538
17. Kirk P, He T, Anderson LJ, Roughton M, Tanner MA, Lam WW, Au WY, Chu WC, Chan G, Galanello R, Matta G, Fogel M, Cohen AR, Tan RS, Chen K, Ng I, Lai A, Fucharoen S, Laothamata J, Chuncharunee S, Jongjirasiri S, Firmin DN, Smith GC, Pennell DJ (2010) International reproducibility of single breathhold T2 MR for cardiac and liver iron assessment among five thalassemia centers. J Magn Reson Imaging 32:315-319
18. Pennell DJ, Berdoukas V, Karagiorga M, Ladis V, Piga A, Aessopos A et al (2006) Randomized controlled trial of deferiprone or deferoxamine in beta-thalassemia major patients with asymptomatic myocardial siderosis. Blood 107(9):3738-3744
19. Tanner MA, Galanello R, Dessi C, Smith GC, Westwood MA, Agus A et al (2007) A randomized, placebo-controlled, doubleblind trial of the effect of combined therapy with deferoxamine and deferiprone on myocardial iron in thalassemia major using cardiovascular magnetic resonance. Circulation 115(14):1876-1884
20. Kirk P, Roughton M, Porter JB,Walker JM, TannerMA, Patel J et al (2009) Cardiac T2 magnetic resonance for prediction of cardiac complications in thalassemia major. Circulation 120(20):1961-1968
21. Smith GC, Carpenter JP, He T, Alam MH, Firmin DN, Pennell DJ (2011) Value of black blood T2 cardiovascular magnetic resonance. J Cardiovasc Magn Reson 13:21
22. Saiviroonporn P, Viprakasit V, Boonyasirinant T, Khuhapinant A, Wood JC, Krittayaphong R (2011) Comparison of the regionbased and pixel-wise methods for cardiac T2 analysis in 50 transfusion-dependent Thai thalassemia patients. J Comput Assist Tomogr 35(3):375-381